Evidence map›Paper›PMID 25821446›Full record

ArticleFrontiers in microbiology2015

Identification and mutational analyses of phosphorylation sites of the calcineurin-binding protein CbpA and the identification of domains required for calcineurin binding in Aspergillus fumigatus.

Praveen R Juvvadi, Yan Ma, Amber D Richards, Erik J Soderblom, M Arthur Moseley, Frédéric Lamoth, William J Steinbach

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Potential Antifungal Targets forInternational journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Aspergillus fumigatus and Aspergillosis in 2019.Clinical microbiology reviews · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Praveen R JuvvadiDivision of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center Durham, NC, USA.
Yan MaDepartment of Dermatology and Venereology, The Second Hospital of Shanxi Medical University Taiyuan, Shanxi, China.
Amber D RichardsDepartment of Dermatology and Venereology, The Second Hospital of Shanxi Medical University Taiyuan, Shanxi, China.
Erik J SoderblomDepartment of Dermatology and Venereology, The Second Hospital of Shanxi Medical University Taiyuan, Shanxi, China.
M Arthur MoseleyDuke Proteomics and Metabolomics Core Facility, Center for Genomic and Computational Biology, Duke University Durham, NC, USA.
Frédéric LamothDivision of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center Durham, NC, USA ; Infectious Diseases Service, Department of Medicine, Lausanne University Hospital Lausanne, Switzerland ; Institute of Microbiology, Lausanne University Hospital Lausanne, Switzerland.
William J SteinbachDivision of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center Durham, NC, USA ; Department of Molecular Genetics and Microbiology, Duke University Medical Center Durham, NC, USA.
Duke Medical Center · USDuke University · USDuke University Hospital · USSecond Hospital of Shanxi Medical University · CNUniversity of Lausanne · CH

Funding

Structural Biological Development of Fungal-Specific Calcineurin InhibitorsR01AI112595 · NIAID · DUKE UNIVERSITY · PI HEITMAN, JOSEPH, SCHUMACHER, MARIA · 2014 to 2017
$2.5M
Instrumentation for Quantitative Phosphoproteomics and AcetylomicsS10OD012266 · OD · DUKE UNIVERSITY · PI MOSELEY, MARTIN ARTHUR · 2014 to 2014
$320k
NIAID NIH HHS R01 AI112595NIH HHS S10 OD012266
6 · The paper itself

Abstract

Calcineurin is a key protein phosphatase required for hyphal growth and virulence in Aspergillus fumigatus, making it an attractive antifungal target. However, currently available calcineurin inhibitors, FK506 and cyclosporine A, are immunosuppressive, limiting usage in the treatment of patients with invasive aspergillosis. Therefore, the identification of endogenous inhibitors of calcineurin belonging to the calcipressin family is an important parallel strategy. We previously identified the gene cbpA as the A. fumigatus calcipressin member and showed its involvement in hyphal growth and calcium homeostasis. However, the mechanism of its activation/inhibition through phosphorylation and its interaction with calcineurin remains unknown. Here we show that A. fumigatus CbpA is phosphorylated at three distinct domains, including the conserved SP repeat motif (phosphorylated domain-I; PD-I), a filamentous fungal-specific domain (PD-II), and the C-terminal CIC motif (Calcipressin Inhibitor of Calcineurin; PD-III). While mutation of three phosphorylated residues (Ser208, Ser217, Ser223) in the PD-II did not affect CbpA function in vivo, mutation of the two phosphorylated serines (Ser156, Ser160) in the SP repeat motif caused reduced hyphal growth and sensitivity to oxidative stress. Mutational analysis in the key domains in calcineurin A (CnaA) and proteomic interaction studies confirmed the requirement of PxIxIT motif-binding residues (352-NIR-354) and the calcineurin B (CnaB)-binding helix residue (V371) for the binding of CbpA to CnaA. Additionally, while the calmodulin-binding residues (442-RVF-444) did not affect CbpA binding to CnaA, three mutations (T359P, H361L, and L365S) clustered between the CnaA catalytic and the CnaB-binding helix were also required for CbpA binding. This is the first study to analyze the phosphorylation status of calcipressin in filamentous fungi and identify the domains required for binding to calcineurin.

Indexed as

Aspergillus fumigatuscalcineurincalcineurin-binding protein (CbpA)mutationphosphorylation

Identifiers

PMID25821446
PMCPMC4358225
OpenAlexW1968153557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.